A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : 15-PGDH

Search Conditions:
Search Keyword : 15-PGDH
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: 15-PGDH
Appearance Frequency: 84 time(s)
Long forms: 29

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
15-prostaglandin dehydrogenase
(26 times)
Neoplasms
(5 times)
COX-2 (11 times)
NSAIDs (5 times)
PCa (5 times)
1987 Identification of 12-keto-5,8,10-heptadecatrienoic acid as an arachidonic acid metabolite produced by human HL-60 leukemia cells.
prostaglandin catabolic enzyme 15-hydroxyprostaglandin dehydrogenase
(13 times)
Neoplasms
(7 times)
COX-2 (8 times)
PGE2 (4 times)
VDR (4 times)
2005 NAD+-linked 15-hydroxyprostaglandin dehydrogenase (15-PGDH) behaves as a tumor suppressor in lung cancer.
15-hydroxy-prostaglandin dehydrogenase
(7 times)
Neoplasms
(2 times)
COX (2 times)
BCC (1 time)
COXibs (1 time)
1987 Effect of dexamethasone on fetal lung 15-hydroxy-prostaglandin dehydrogenase: possible mechanism for the prevention of patent ductus arteriosus by maternal dexamethasone therapy.
placental NAD+-dependent 15-hydroxyprostaglandin dehydrogenase
(6 times)
Biochemistry
(3 times)
PGE2 (2 times)
CRC (1 time)
CUMS (1 time)
1996 Site-directed mutagenesis of the conserved serine 138 of human placental NAD+-dependent 15-hydroxyprostaglandin dehydrogenase to an alanine results in an inactive enzyme.
15-hydroxy-PG dehydrogenase
(4 times)
Reproductive Medicine
(1 time)
PGT (2 times)
CBR1 (1 time)
COX (1 time)
2004 Prostaglandin E2 as a mediator of fever: synthesis and catabolism.
protein level of 15-hydroxyprostaglandin dehydrogenase
(3 times)
Cell Biology
(1 time)
ALS (1 time)
CAC (1 time)
COX-2 (1 time)
2009 15-Hydroxyprostaglandin dehydrogenase inactivation as a mechanism of resistance to celecoxib chemoprevention of colon tumors.
present study was to investigate the function of 15-hydroxyprostaglandin dehydrogenase
(2 times)
Neoplasms
(1 time)
AKI (1 time)
COX-2 (1 time)
LPS (1 time)
2014 Expression of 15-hydroxyprostaglandin dehydrogenase and cyclooxygenase-2 in non-small cell lung cancer: Correlations with angiogenesis and prognosis.
process mediated by the nicotinamide adenine dinucleotide (NAD+)-dependent 15-hydroxyprostaglandin dehydrogenase
(2 times)
Neoplasms
(1 time)
HGF (2 times)
COX (1 time)
COX-2 (1 time)
2009 HGF/Met signalling promotes PGE(2) biogenesis via regulation of COX-2 and 15-PGDH expression in colorectal cancer cells.
15-PG dehydrogenase
(1 time)
Orthopedics
(1 time)
COX-2 (1 time)
CS (1 time)
IL-1beta (1 time)
2012 A potential role of chondroitin sulfate on bone in osteoarthritis: inhibition of prostaglandin E₂ and matrix metalloproteinases synthesis in interleukin-1beta-stimulated osteoblasts.
10  P450 isoform CYP4B1, 15-hydroxyprostaglandin dehydrogenase
(1 time)
Cell Biology
(1 time)
RGDI (1 time)
TFF1 (1 time)
2004 Thiamine transporter gene expression and exogenous thiamine modulate the expression of genes involved in drug and prostaglandin metabolism in breast cancer cells.
11  pathway by ubiquitously abrogating expression of 15-hydroxyprostaglandin dehydrogenase
(1 time)
Science
(1 time)
COX-2 (1 time)
2004 15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancers.
12  pathway, with HPGD encoding the degradative enzyme 15-hydroxyprostaglandin dehydrogenase
(1 time)
Neoplasms
(1 time)
NSAID (1 time)
PGE2 (1 time)
2014 Inactivating mutation in the prostaglandin transporter gene, SLCO2A1, associated with familial digital clubbing, colon neoplasia, and NSAID resistance.
13  pattern of expression of 15-hydroxyprostaglandin dehydrogenase
(1 time)
Neoplasms
(1 time)
COX-2 (1 time)
PG (1 time)
2010 Reduction of 15-hydroxyprostaglandin dehydrogenase expression is an independent predictor of poor survival associated with enhanced cell proliferation in gastric adenocarcinoma.
14  performed to determine human 15-hydroxyprostaglandin dehydrogenase
(1 time)
Biochemistry
(1 time)
PGE2 (1 time)
2005 Understanding human 15-hydroxyprostaglandin dehydrogenase binding with NAD+ and PGE2 by homology modeling, docking and molecular dynamics simulation.
15  PGE(2) and colocalizes with 15-hydroxyprostaglandin dehydrogenase
(1 time)
Nephrology
(1 time)
mOAT-PG (1 time)
2012 Sex hormones induce a gender-related difference in renal expression of a novel prostaglandin transporter, OAT-PG, influencing basal PGE2 concentration.
16  PGE2 such as 15-hydroxyprostaglandin dehydrogenase
(1 time)
Endocrinology
(1 time)
--- 1989 Prostaglandin catabolism in fetal and maternal tissues--a study of 15-hydroxyprostaglandin dehydrogenase and delta 13 reductase with specific assay methods.
17  PGE2, although the degradation enzyme 15-hydroxyprostaglandin dehydrogenase
(1 time)
Molecular Biology
(1 time)
ATRA (1 time)
PDAC (1 time)
PGE2 (1 time)
2019 Inhibition of 15-PGDH causes Kras-driven tumor expansion through prostaglandin E2-ALDH1 signaling in the pancreas.
18  PGF(2alpha) catabolism, 15-hydroxyprostaglandin dehydrogenase
(1 time)
Brain
(1 time)
2alpha (1 time)
PGs (1 time)
2000 Perinatal changes in choroidal 15-hydroxyprostaglandin dehydrogenase: implications for prostaglandin removal from brain.
19  porcine endometrium NAD-dependent 15-hydroxyprostaglandin dehydrogenase
(1 time)
Reproductive Medicine
(1 time)
IL-1 beta (1 time)
IL-6 (1 time)
PGF2 alpha (1 time)
2012 The effect of tumor necrosis factor alpha (TNFalpha), interleukin 1beta (IL1beta) and interleukin 6 (IL6) on endometrial PGF2alpha synthesis, metabolism and release in early-pregnant pigs.
20  porcine ocular tissues contain 15-hyroxyprostaglandin dehydrogenase
(1 time)
Endocrinology
(1 time)
PGF2 alpha (1 time)
1994 Corneal permeability to and ocular metabolism of phenyl substituted prostaglandin esters in vitro.
21  potent inhibitors of 15-hydroxyprostaglandin dehydrogenase
(1 time)
Endocrinology
(1 time)
PGE2 (1 time)
2014 Wound healing effects of new 15-hydroxyprostaglandin dehydrogenase inhibitors.
22  presence and activity of endometrial NAD-dependent 15-hydroxyprostaglandin dehydrogenase
(1 time)
Reproductive Medicine
(1 time)
IL-1 beta (1 time)
IL-6 (1 time)
PGF2 alpha (1 time)
2012 The effect of tumor necrosis factor alpha (TNFalpha), interleukin 1beta (IL1beta) and interleukin 6 (IL6) on endometrial PGF2alpha synthesis, metabolism and release in early-pregnant pigs.
23  previously reported an induction of 15-hydroxyprostaglandin dehydrogenase type I mRNA
(1 time)
Endocrinology
(1 time)
COX2 (1 time)
PG (1 time)
PGE2 (1 time)
2001 Indomethacin increases 15-PGDH mRNA expression in HL60 cells differentiated by PMA.
24  Prior to cervical ripening at term, 15-hydroxyprostaglandin dehydrogenase
(1 time)
Endocrinology
(1 time)
EP2 (1 time)
PGE2 (1 time)
2014 Prostaglandin E2 regulates its own inactivating enzyme, 15-PGDH, by EP2 receptor-mediated cervical cell-specific mechanisms.
25  production, COX-1 and NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase
(1 time)
Neoplasms
(1 time)
COX (1 time)
CRC (1 time)
2013 Effect of ginger root on cyclooxygenase-1 and 15-hydroxyprostaglandin dehydrogenase expression in colonic mucosa of humans at normal and increased risk for colorectal cancer.
26  proliferation and increases activity of 15-hydroxyprostaglandin-dehydrogenase
(1 time)
Endocrinology
(1 time)
NSAIDs (1 time)
PG (1 time)
2006 15-Hydroxyprostaglandin-dehydrogenase is involved in anti-proliferative effect of non-steroidal anti-inflammatory drugs COX-1 inhibitors on a human medullary thyroid carcinoma cell line.
27  prostate epithelial cells and increased 15-hydroxyprostaglandin dehydrogenase
(1 time)
Neoplasms
(1 time)
COX-2 (1 time)
PCa (1 time)
PGs (1 time)
2009 Inhibition of prostaglandin synthesis and actions by genistein in human prostate cancer cells and by soy isoflavones in prostate cancer patients.
28  protein expressions of COX-1, mPGES-2, cPGES, and 15-hydroxyprostaglandin dehydrogenase
(1 time)
Peroxisome Proliferator-Activated Receptors
(1 time)
DN (1 time)
PG (1 time)
PPAR (1 time)
2013 PPARgamma Agonist Rosiglitazone Suppresses Renal mPGES-1/PGE2 Pathway in db/db Mice.
29  qRT-PCR, mPGES-1, mPGES-2, cPGES and 15-hydroxyprostaglandin dehydrogenase
(1 time)
Medicine
(1 time)
DN (1 time)
PGE2 (1 time)
2014 COX-2 but not mPGES-1 contributes to renal PGE2 induction and diabetic proteinuria in mice with type-1 diabetes.